Published in Dermatol Surg on April 01, 2004
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS One (2013) 0.95
Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? Front Immunol (2014) 0.93
A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions. Carcinogenesis (2008) 0.91
Molecular markers in cutaneous squamous cell carcinoma. Int J Surg Oncol (2011) 0.83
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol (2015) 0.81
Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs. Int J Cancer (2010) 0.79
Cancer stem cells and immunoresistance: clinical implications and solutions. Transl Lung Cancer Res (2015) 0.79
Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis. J Neurol (2009) 0.79
Focus Issue on Squamous Cell Carcinoma: Practical Concerns Regarding the 7th Edition AJCC Staging Guidelines. J Skin Cancer (2010) 0.79
Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer. PLoS One (2015) 0.78
Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs. Biochem Biophys Res Commun (2012) 0.78
Care of the liver transplant patient. Can J Gastroenterol Hepatol (2014) 0.77
Merkel cell carcinoma of the head and neck: a single institutional experience. J Skin Cancer (2013) 0.77
The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clin Med Insights Oncol (2011) 0.76
Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci (2010) 0.76
Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors. An Bras Dermatol (2016) 0.75
Study of factors affecting the incidence of skin cancer in patients after liver transplant. An Bras Dermatol (2017) 0.75
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol (2006) 4.88
[Dithranol in the treatment of scalp psoriasis]. J Dtsch Dermatol Ges (2003) 2.63
Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b. Dermatology (2002) 2.37
IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol (2007) 1.80
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) (2009) 1.76
Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res (2005) 1.65
Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol (2008) 1.59
Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg (2004) 1.58
Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm (2006) 1.56
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
Immunopathogenesis of psoriasis. Exp Dermatol (2007) 1.44
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.44
Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol (2006) 1.41
Sunscreens in organ transplant patients. Nephrol Dial Transplant (2008) 1.40
Skin changes following organ transplantation: an interdisciplinary challenge. Dtsch Arztebl Int (2014) 1.39
Virtual dermatohistopathology at http://www.pathowiki.org. J Dtsch Dermatol Ges (2012) 1.39
Clinical research in cutaneous T-cell lymphoma moving forward. Arch Dermatol (2008) 1.39
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma. J Immunother (2008) 1.35
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol (2006) 1.31
Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. J Clin Oncol (2010) 1.29
Porcine ear skin: an in vitro model for human skin. Skin Res Technol (2007) 1.28
Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol (2008) 1.26
S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges (2012) 1.25
Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer (2006) 1.21
Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging (2003) 1.20
The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur J Immunol (2009) 1.19
Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers (2007) 1.19
PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol (2007) 1.15
Variations of hair follicle size and distribution in different body sites. J Invest Dermatol (2004) 1.15
Biology of tumor necrosis factor-alpha- implications for psoriasis. Exp Dermatol (2004) 1.14
Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res (2006) 1.12
Multiple evolutionary mechanisms drive papillomavirus diversification. Mol Biol Evol (2007) 1.10
The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol (2007) 1.10
IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med (2013) 1.09
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08
One-year study on the variation of carotenoid antioxidant substances in living human skin: influence of dietary supplementation and stress factors. J Biomed Opt (2008) 1.08
Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg (2004) 1.07
Treatment of psoriasis with fumaric acid esters (Fumaderm). J Dtsch Dermatol Ges (2007) 1.05
Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One (2012) 1.04
Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol (2010) 1.04
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. J Immunother (2010) 1.04
Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res (2009) 1.04
Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol (2006) 1.04
Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging (2006) 1.03
Selective follicular targeting by modification of the particle sizes. J Control Release (2010) 1.03
Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients. J Gen Virol (2011) 1.03
Novel immunotherapies for psoriasis. Trends Immunol (2002) 1.01
Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm (2007) 1.01
Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin. Neurochem Res (2002) 1.01
Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol (2009) 1.01
Clinical applicability of in vivo fluorescence confocal microscopy for noninvasive diagnosis and therapeutic monitoring of nonmelanoma skin cancer. J Biomed Opt (2008) 1.00
Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncol Rep (2006) 1.00
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol (2008) 1.00
Current state of vitiligo therapy--evidence-based analysis of the literature. J Dtsch Dermatol Ges (2007) 0.99
Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol (2005) 0.99
Follicular transport route--research progress and future perspectives. Eur J Pharm Biopharm (2008) 0.98
Clinical investigations of Toll-like receptor agonists. Expert Opin Investig Drugs (2008) 0.98
Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol (2007) 0.97
Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One (2011) 0.97
mTOR inhibitor-associated dermatologic and mucosal problems. Clin Transplant (2010) 0.97
Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. J Exp Med (2011) 0.97
[S3-guidelines for the treatment of psoriasis vulgaris Update 2011]. J Dtsch Dermatol Ges (2011) 0.96
Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol (2006) 0.96
Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol (2006) 0.95
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results. Vaccine (2005) 0.94
Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol (2005) 0.94
Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int (2003) 0.94
Gender-related differences in the physiology of the stratum corneum. Dermatology (2005) 0.94
Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. J Invest Dermatol (2009) 0.93
Genomic characterization of the first insectivoran papillomavirus reveals an unusually long, second non-coding region and indicates a close relationship to Betapapillomavirus. J Gen Virol (2009) 0.93
Application of optical non-invasive methods in skin physiology: a comparison of laser scanning microscopy and optical coherent tomography with histological analysis. Skin Res Technol (2007) 0.93
Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol (2007) 0.93
Peritumoral clefting in basal cell carcinoma: correlation of in vivo reflectance confocal microscopy and routine histology. J Cutan Pathol (2010) 0.93
In vivo skin treatment with tissue-tolerable plasma influences skin physiology and antioxidant profile in human stratum corneum. Exp Dermatol (2011) 0.93
Isolation of three novel rat and mouse papillomaviruses and their genomic characterization. PLoS One (2012) 0.92
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol (2010) 0.92
Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm (2008) 0.92
Isolation and genomic characterization of the first Norway rat (Rattus norvegicus) papillomavirus and its phylogenetic position within Pipapillomavirus, primarily infecting rodents. J Gen Virol (2009) 0.92
Combined in vivo multiphoton and CARS imaging of healthy and disease-affected human skin. Microsc Res Tech (2011) 0.91
Resiquimod, a topical drug for viral skin lesions and skin cancer. Expert Opin Investig Drugs (2012) 0.91
Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart. Virology (2010) 0.91
Water-filtered infrared-A (wIRA) can act as a penetration enhancer for topically applied substances. Ger Med Sci (2008) 0.91
Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol (2010) 0.91
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One (2010) 0.91
Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy. Melanoma Res (2006) 0.91
Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol (2011) 0.91
Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy (2004) 0.91
Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells. J Invest Dermatol (2007) 0.90
The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. J Invest Dermatol (2009) 0.90
Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand. J Invest Dermatol (2011) 0.90
Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch Dermatol Res (2005) 0.90
Nanoparticles in dermatology. Arch Dermatol Res (2011) 0.90
Persistent agmination of lymphomatoid papulosis: not a new entity, but localized lymphomatoid papulosis. J Am Acad Dermatol (2008) 0.90
Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses. Dermatol Surg (2008) 0.89